Bicheng Chen

4.2k total citations · 1 hit paper
129 papers, 3.3k citations indexed

About

Bicheng Chen is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Bicheng Chen has authored 129 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 39 papers in Surgery and 31 papers in Oncology. Recurrent topics in Bicheng Chen's work include Pancreatitis Pathology and Treatment (21 papers), Pancreatic and Hepatic Oncology Research (16 papers) and Liver Disease Diagnosis and Treatment (14 papers). Bicheng Chen is often cited by papers focused on Pancreatitis Pathology and Treatment (21 papers), Pancreatic and Hepatic Oncology Research (16 papers) and Liver Disease Diagnosis and Treatment (14 papers). Bicheng Chen collaborates with scholars based in China, United States and Sweden. Bicheng Chen's co-authors include Mengtao Zhou, Cheng‐Le Zhuang, Xing-Zhao Ye, Fujun Yu, Peihong Dong, Jianjian Zheng, Zhentao Yu, Xiaodong Zhang, Hongwei Sun and Yongheng Bai and has published in prestigious journals such as PLoS ONE, Journal of Applied Physics and Scientific Reports.

In The Last Decade

Bicheng Chen

127 papers receiving 3.3k citations

Hit Papers

Enhanced Recovery After Surgery Programs Versus Tradition... 2013 2026 2017 2021 2013 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bicheng Chen China 31 1.6k 828 792 567 432 129 3.3k
Zheng Wu China 34 1.4k 0.9× 657 0.8× 825 1.0× 996 1.8× 448 1.0× 149 3.2k
Satoshi Shimizu Japan 30 1.9k 1.2× 572 0.7× 712 0.9× 838 1.5× 1.2k 2.8× 135 4.3k
Jie Zhao China 34 1.9k 1.2× 353 0.4× 471 0.6× 415 0.7× 467 1.1× 127 3.5k
Jianjun Zhang China 25 796 0.5× 766 0.9× 460 0.6× 292 0.5× 492 1.1× 126 2.2k
Iain H. McKillop United States 31 1.3k 0.8× 733 0.9× 486 0.6× 425 0.7× 982 2.3× 134 3.6k
Pengfei Yu China 27 1.2k 0.7× 795 1.0× 593 0.7× 726 1.3× 439 1.0× 137 2.9k
Tian Lan China 38 2.3k 1.5× 487 0.6× 892 1.1× 587 1.0× 920 2.1× 134 4.5k
You Zhou Finland 30 1.4k 0.9× 400 0.5× 709 0.9× 236 0.4× 1.2k 2.9× 104 3.2k
Zhi Zeng China 31 1.6k 1.0× 724 0.9× 632 0.8× 475 0.8× 359 0.8× 127 3.5k
Quancheng Kan China 35 2.5k 1.5× 405 0.5× 1.2k 1.5× 515 0.9× 584 1.4× 118 4.0k

Countries citing papers authored by Bicheng Chen

Since Specialization
Citations

This map shows the geographic impact of Bicheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bicheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bicheng Chen more than expected).

Fields of papers citing papers by Bicheng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bicheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bicheng Chen. The network helps show where Bicheng Chen may publish in the future.

Co-authorship network of co-authors of Bicheng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Bicheng Chen. A scholar is included among the top collaborators of Bicheng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bicheng Chen. Bicheng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Yihui, et al.. (2024). Platelet Membrane-Encapsulated Poly(lactic-co-glycolic acid) Nanoparticles Loaded with Sildenafil for Targeted Therapy of Vein Graft Intimal Hyperplasia. International Journal of Pharmaceutics X. 8. 100278–100278. 4 indexed citations
3.
Zhou, Xiang, Wei‐Ming Wang, Cheng Wang, et al.. (2019). DPP4 Inhibitor Attenuates Severe Acute Pancreatitis-Associated Intestinal Inflammation via Nrf2 Signaling. Oxidative Medicine and Cellular Longevity. 2019. 1–11. 33 indexed citations
4.
Xiang, Yukai, et al.. (2019). Downregulation of TNF-α/TNF-R1 Signals by AT-Lipoxin A4 May Be a Significant Mechanism of Attenuation in SAP-Associated Lung Injury. Mediators of Inflammation. 2019. 1–13. 16 indexed citations
5.
Ye, Wen, Dinglai Yu, Fan Zhang, et al.. (2019). Lipoxin A4 Ameliorates Acute Pancreatitis-Associated Acute Lung Injury through the Antioxidative and Anti-Inflammatory Effects of the Nrf2 Pathway. Oxidative Medicine and Cellular Longevity. 2019. 1–15. 38 indexed citations
6.
Wang, Cheng, et al.. (2019). <p>Baohuoside I Inhibits the Proliferation of Pancreatic Cancer Cells via mTOR/S6K1-Caspases/Bcl2/Bax Apoptotic Signaling</p>. Cancer Management and Research. Volume 11. 10609–10621. 13 indexed citations
7.
Hong, Weilong, Ge Zhang, Hong Lu, et al.. (2019). Epithelial and interstitial Notch1 activity contributes to the myofibroblastic phenotype and fibrosis. Cell Communication and Signaling. 17(1). 145–145. 26 indexed citations
8.
Zhao, Liang, et al.. (2018). TRIM24 promotes hepatocellular carcinoma progression via AMPK signaling. Experimental Cell Research. 367(2). 274–281. 17 indexed citations
9.
Shi, Keqing, Peng Li, Bicheng Chen, et al.. (2018). A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection. Clinica Chimica Acta. 485. 187–194. 9 indexed citations
10.
Yu, Fujun, et al.. (2017). Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2. Cellular Physiology and Biochemistry. 43(6). 2242–2252. 33 indexed citations
11.
Yu, Fujun, Yong Guo, Bicheng Chen, et al.. (2017). LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p. Cellular Physiology and Biochemistry. 41(5). 1970–1980. 48 indexed citations
12.
Yu, Fujun, Zhongqiu Lu, Bicheng Chen, Peihong Dong, & Jianjian Zheng. (2016). Identification of a Novel lincRNA-p21-miR-181b-PTEN Signaling Cascade in Liver Fibrosis. Mediators of Inflammation. 2016. 1–10. 55 indexed citations
13.
Xia, Peng, et al.. (2016). Lycopene Ameliorates Transplant Arteriosclerosis in Vascular Allograft Transplantation by Regulating the NO/cGMP Pathways and Rho‐Associated Kinases Expression. Oxidative Medicine and Cellular Longevity. 2016(1). 3128280–3128280. 14 indexed citations
14.
Yu, Fujun, Yong Guo, Bicheng Chen, Peihong Dong, & Jianjian Zheng. (2015). MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Laboratory Investigation. 95(7). 781–789. 71 indexed citations
15.
Yang, Lihong, Silu Wang, Lili Tang, et al.. (2014). Universal Stem-Loop Primer Method for Screening and Quantification of MicroRNA. PLoS ONE. 9(12). e115293–e115293. 62 indexed citations
17.
Zhuang, Cheng‐Le, Shu Liu, Weizhe Chen, et al.. (2014). Ginsenoside Rb1 improves postoperative fatigue syndrome by reducing skeletal muscle oxidative stress through activation of the PI3K/Akt/Nrf2 pathway in aged rats. European Journal of Pharmacology. 740. 480–487. 67 indexed citations
18.
Chen, Bicheng. (2013). Relationship between genetic polymorphisms of CYP1A1,NQO1 and EPHX1 and susceptibility to bladder cancer. Zhonghua zhongliu fangzhi zazhi. 4 indexed citations
19.
Shan, Yunfeng, Yuan‐Lan Huang, Bicheng Chen, et al.. (2010). Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status. Medical Oncology. 28(4). 1012–1016. 79 indexed citations
20.
Deng, Liming, Qiyu Zhang, Jiying Zhu, et al.. (2009). A canine portal hypertension model induced by intra‐portal administration of Sephadex microsphere. Journal of Gastroenterology and Hepatology. 25(4). 778–785. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026